Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-05-21 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1373 characters) and begins with 'RNS Number : 6574N', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or CAP). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, MANG, or DIV, the most appropriate classification is the general regulatory fallback category.
2020-05-21 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1356 characters) and begins with an 'RNS Number', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms, not a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a general regulatory announcement that doesn't fit into the more specific categories (like DIRS, MANG, or DIV), the most appropriate classification is the general regulatory filing fallback category.
2020-05-21 English
Distribution Agreement for COVID-19 Antigen Test
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 4012N' and is dated May 20, 2020. It announces a specific corporate event: an exclusive distribution agreement for a COVID-19 antigen test. The structure, including the RNS header, the announcement of a material event (a new agreement/partnership), and the concluding boilerplate text referencing RNS and the London Stock Exchange, strongly indicates this is a regulatory news service announcement. Since it is a specific, material announcement that doesn't fit the definitions for 10-K, ER, or IR, the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly sourced from the RNS service.
2020-05-20 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1373 characters) and begins with an 'RNS Number' and the issuer name, indicating it is a regulatory news service announcement from the London Stock Exchange. The content specifically discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or CAP). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, MANG, or DIV, the most appropriate classification is the general regulatory filing fallback category, RNS.
2020-05-15 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1356 characters) and begins with an 'RNS Number' and the issuer name, Avacta Group PLC. The content discusses a 'Price Monitoring Extension' related to trading mechanisms on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or DLST, the most appropriate fallback category is Regulatory Filings (RNS).
2020-05-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1373 characters) and begins with an 'RNS Number', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls. This type of miscellaneous, non-standard regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing/announcement category.
2020-05-15 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.